Identification of homozygous missense variant in SIX5 gene underlying recessive nonsyndromic hearing impairment.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 30 05 2021
accepted: 21 04 2022
entrez: 16 6 2022
pubmed: 17 6 2022
medline: 22 6 2022
Statut: epublish

Résumé

Hearing impairment (HI) is a heterogeneous condition that affects many individuals globally with different age groups. HI is a genetically and phenotypically heterogeneous disorder. Over the last several years, many genes/loci causing rare autosomal recessive and dominant forms of hearing impairments have been identified, involved in various aspects of ear development. In the current study, two affected individuals of a consanguineous family exhibiting autosomal recessive nonsyndromic hearing impairment (AR-NSHI) were clinically and genetically characterized. The single affected individual (IV-2) of the family was subjected to whole-exome sequencing (WES) accompanied by traditional Sanger sequencing. Clinical examinations using air conduction audiograms of both the affected individuals showed profound hearing loss across all frequencies. WES revealed a homozygous missense variant (c.44G>C) in the SIX5 gene located on chromosome 19q13.32. We report the first case of autosomal recessive NSHI due to a biallelic missense variant in the SIX5 gene. This report further supports the evidence that the SIX5 variant might cause profound HI and supports its vital role in auditory function. Identification of novel candidate genes might help in application of future gene therapy strategies that may be implemented for NSHI, such as gene replacement using cDNA, gene silencing using RNA interference, and gene editing using the CRISPR/Cas9 system.

Identifiants

pubmed: 35709191
doi: 10.1371/journal.pone.0268078
pii: PONE-D-21-17073
pmc: PMC9202841
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0268078

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nat Genet. 2002 Mar;30(3):277-84
pubmed: 11850618
Bioinformatics. 2012 Nov 1;28(21):2747-54
pubmed: 22942019
Front Biosci (Landmark Ed). 2012 Jun 01;17(6):2213-36
pubmed: 22652773
J Med Genet. 2005 Oct;42(10):e61
pubmed: 16033917
Hum Mutat. 2011 Feb;32(2):183-90
pubmed: 21280147
Eur J Hum Genet. 2021 Feb;29(2):338-342
pubmed: 32939038
Clin Genet. 1999 Oct;56(4):306-12
pubmed: 10636449
Nat Genet. 1998 Dec;20(4):370-3
pubmed: 9843210
Nat Genet. 1999 Sep;23(1):16-8
pubmed: 10471490
Clin Genet. 2003 Jul;64(1):65-9
pubmed: 12791041
Genomics Inform. 2018 Dec;16(4):e20
pubmed: 30602081
Hum Mol Genet. 1996 Feb;5(2):223-9
pubmed: 8824878
Gene. 2000 Apr 18;247(1-2):145-51
pubmed: 10773454
N Engl J Med. 2002 Jan 24;346(4):243-9
pubmed: 11807148
J Hum Genet. 2019 Feb;64(2):153-160
pubmed: 30498240
Int J Pediatr Otorhinolaryngol. 2014 Dec;78(12):2026-36
pubmed: 25281338
Am J Hum Genet. 2007 Apr;80(4):800-4
pubmed: 17357085
Am J Med Genet. 1986 Sep;25(1):15-27
pubmed: 3799714
Front Neurol. 2017 Feb 09;8:31
pubmed: 28232817
BMC Bioinformatics. 2008 Jan 23;9:40
pubmed: 18215316
Nature. 1997 May 1;387(6628):80-3
pubmed: 9139825
Nat Genet. 2000 May;25(1):105-9
pubmed: 10802667
Gigascience. 2021 Feb 16;10(2):
pubmed: 33590861
Am J Med Genet. 1978;2(3):241-52
pubmed: 263442
Hum Mol Genet. 1995 Oct;4(10):1919-25
pubmed: 8595416
Nat Genet. 1997 Aug;16(4):407-9
pubmed: 9241283
Hum Mol Genet. 1999 Mar;8(3):481-92
pubmed: 9949207
Curr Mol Med. 2009 Jun;9(5):546-64
pubmed: 19601806
J Hematol Oncol. 2016 Nov 8;9(1):119
pubmed: 27821176
PLoS One. 2017 Jun 2;12(6):e0177912
pubmed: 28574986
Hum Mol Genet. 1996 Jan;5(1):169-73
pubmed: 8789457
N Engl J Med. 2006 May 18;354(20):2151-64
pubmed: 16707752
Cytogenet Cell Genet. 1999;87(1-2):108-12
pubmed: 10640827
Front Genet. 2021 Feb 04;12:630787
pubmed: 33613643
J Hum Genet. 2020 Jan;65(2):187-192
pubmed: 31656313
Am J Med Genet. 1980;7(3):341-9
pubmed: 7468659
J Mol Biol. 2001 Jan 19;305(3):567-80
pubmed: 11152613
Bioinformatics. 2009 Nov 1;25(21):2865-71
pubmed: 19561018
Genomics. 1999 Oct 1;61(1):82-91
pubmed: 10512683
Front Genet. 2018 Nov 06;9:447
pubmed: 30459804
J Hum Genet. 2016 Mar;61(3):207-13
pubmed: 26538303
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8090-5
pubmed: 15141091

Auteurs

Mohib Ullah Kakar (MU)

Faculty of Marine Sciences, Lasbela University of Agriculture, Water and Marine Sciences (LUAWMS), Uthal, Balochistan, Pakistan.

Muhammad Akram (M)

Department of Life Sciences, School of Science, University of Management and Technology (UMT), Lahore, Pakistan.

Muhammad Zubair Mehboob (M)

CAS Center for Excellence in Biotic Interaction, College of Life Sciences, University of Chinese Academy of Science, Beijing, China.

Muhammad Younus (M)

State Key Laboratory of Membrane Biology, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, Peking-Tsinghua Center for Life Sciences, PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China.

Muhammad Bilal (M)

Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.

Ahmed Waqas (A)

Division of Science and Technology, Department of Zoology, University of Education Lahore, Lahore, Pakistan.

Amina Nazir (A)

Institute of Animal Science and Veterinary Medicine, Shandong Academy of Agricultural Sciences, Shandong Province, China.

Muhammad Shafi (M)

Faculty of Marine Sciences, Lasbela University of Agriculture, Water and Marine Sciences (LUAWMS), Uthal, Balochistan, Pakistan.

Muhammad Umair (M)

Department of Life Sciences, School of Science, University of Management and Technology (UMT), Lahore, Pakistan.

Sajjad Ahmad (S)

Faculty of Veterinary and Animal Sciences, Lasbela University of Agriculture, Water and Marine Sciences (LUAWMS), Uthal, Balochistan, Pakistan.

Misbahuddin M Rafeeq (MM)

Department of Pharmacology, Faculty of Medicine, Rabigh King Abdul Aziz University, Jeddah, KSA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH